Sera Prognostics (SERA) Total Debt (2020)

Sera Prognostics posted quarterly Total Debt of $4.7 million for Q4 2020.

Sera Prognostics (SERA) has 1 years of Total Debt data on file, last reported at $4.7 million in Q4 2020.

  • For the quarter ending Q4 2020, Total Debt changed N/A year-over-year to $4.7 million; the trailing twelve-month figure through Dec 2020 stood at $4.7 million (changed N/A YoY), and the FY2020 full-year result was $4.7 million, changed N/A from the prior year.
  • Total Debt for Q4 2020 stood at $4.7 million.
  • Across five years, Total Debt topped out at $4.7 million in Q4 2020 and bottomed at $4.7 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 34.05 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.72 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.93 Bn
10 Sera Prognostics 30.02 Mn 30.02 Mn -28,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 4.70 Mn